Haemonetics Corp. buy Citigroup Inc.
Start price
09.07.25
/
50%
€65.00
Target price
09.07.26
€76.78
Performance (%)
-0.77%
End price
10.07.26
€64.50
Summary
This prediction ended on 10.07.26 with a price of €64.50. During the runtime of the prediction for Haemonetics Corp. the price only changed by -0.77%. Citigroup_Inc_ has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | 5.797% | 5.797% | - |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€41.40
07.10.25
07.10.25
€54.71
07.10.26
07.10.26
75.12%
28.07.26
28.07.26
